CME Group Inc. (NASDAQ:CME) Shares Sold by Capital Management Corp VA

Capital Management Corp VA reduced its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,416 shares of the financial services provider's stock after selling 1,257 shares during the period. CME Group accounts for about 1.5% of Capital Management Corp VA's holdings, making the stock its 29th biggest holding. Capital Management Corp VA's holdings in CME Group were worth $8,600,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Heartland Bank & Trust Co purchased a new position in CME Group during the first quarter worth about $377,000. Catalyst Capital Advisors LLC boosted its stake in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after buying an additional 2,636 shares during the period. OMNI 360 Wealth Inc. purchased a new position in CME Group during the first quarter worth about $367,000. Fulcrum Equity Management purchased a new position in CME Group during the first quarter worth about $258,000. Finally, Aspire Growth Partners LLC purchased a new position in CME Group during the fourth quarter worth about $548,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Down 1.1%

Shares of NASDAQ CME traded down $3.12 during midday trading on Friday, hitting $274.70. The company's stock had a trading volume of 2,197,249 shares, compared to its average volume of 2,181,258. CME Group Inc. has a 1 year low of $193.25 and a 1 year high of $290.79. The business's fifty day simple moving average is $275.89 and its two-hundred day simple moving average is $260.65. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $98.99 billion, a price-to-earnings ratio of 27.64, a price-to-earnings-growth ratio of 4.86 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the firm earned $2.50 earnings per share. The firm's quarterly revenue was up 10.4% on a year-over-year basis. On average, equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's dividend payout ratio is currently 50.30%.

Insider Buying and Selling

In related news, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the transaction, the insider owned 8,336 shares in the company, valued at $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Larry G. Gerdes sold 2,000 shares of CME Group stock in a transaction that occurred on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the transaction, the director owned 38,651 shares of the company's stock, valued at $10,207,729.10. This represents a 4.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock valued at $3,680,610 over the last ninety days. 0.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

CME has been the subject of several research analyst reports. UBS Group increased their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Morgan Stanley increased their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. Finally, JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group currently has an average rating of "Hold" and an average price target of $261.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.